Ignite Creation Date:
2024-05-05 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00658606
Status:
COMPLETED
Last Update Posted:
2013-01-08
First Post:
2008-04-10
Brief Title:
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy nbUVB vs Alefacept Alone in Chronic Plaque Psoriasis Subjects
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Study Overview
Official Title:
Efficacy and Safety of Alefacept in Combination With Narrow-band UVB nbUVB Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
COMPLETED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Assess the efficacy and safety of alefacept with nbUVB compared to alefacept alone in chronic plaque psoriasis subjects Combination therapy may improve the clinical response to psoriatic subjects as both modalities have an effect on T cells
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None